ELIQUIS

🇺🇸 United States

FDA Page

Effective Date: Sep 11, 2026
Approval ID: 7be1f4c1-bb2f-4ded-ae9a-515d2a22f93e
Products: 0 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ELIQUIS safely and effectively. See full prescribing information for ELIQUIS. ELIQUIS (apixaban) tablets, for oral use ELIQUIS (apixaban) tablets for oral suspension ELIQUIS SPRINKLE (apixaban) for oral suspension Initial U.S. Approval: 2012

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.